Browse "College of Life Science and Bioengineering(생명과학기술대학)" by Subject immunotherapy

Showing results 1 to 15 of 15

1
Bispecific small molecule-antibody conjugate targeting prostate cancer

Kim, Chan Hyuk; Axup, Jun Y.; Lawson, Brian R.; Yun, Hwayoung; Tardif, Virginie; Choi, Sei Hyun; Zhou, Quan; et al, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, v.110, no.44, pp.17796 - 17801, 2013-10

2
Combination of a STAT3 inhibitor with anti-PD-1 immunotherapy is an effective treatment regimen for a vemurafenib-resistant melanoma

Kim, Tae Woo; Kim, Yujin; Keum, Hyeongseop; Jung, Wonsik; Kang, Minho; Jon, Sangyong, MOLECULAR THERAPY-ONCOLYTICS, v.26, pp.1 - 14, 2022-09

3
Current Understanding of Hypoxia in Glioblastoma Multiforme and Its Response to Immunotherapy

Park, Jang Hyun; Lee, Heung Kyu, CANCERS, v.14, no.5, 2022-03

4
Development of a novel mouse model of vitiligo and inhibition of autoreactive CD8+ T cells by competitive peptides = 새로운 백반증 마우스 모델 확립 및 경쟁 펩타이드를 이용한 자가반응 CD8+ T 세포 억제link

You, Soo-Seong; 유수성; et al, 한국과학기술원, 2013

5
Engineering second-generation TCR-T cells by site-specific integration of TRAF-binding motifs into the CD247 locus

Lah, Sangjoon; Kim, Segi; Kang, In; Kim, Hyojin; Hupperetz, Cedric; Jung, Hyuncheol; Choi, Hyeong Ryeol; et al, JOURNAL FOR IMMUNOTHERAPY OF CANCER, v.11, no.4, 2023-04

6
Harnessing type I interferon-mediated immunity to target malignant brain tumors

Lim, Juhee; Kang, In; La, Jeongwoo; Ku, Keun Bon; Kang, Byeong Hoon; Kim, Yumin; Park, Won Hyung; et al, FRONTIERS IN IMMUNOLOGY, v.14, 2023-05

7
Immune-based therapy for chronic hepatitis C

Chang, Dong-Yeop; Shin, Eui-Cheol, JOURNAL OF LEUKOCYTE BIOLOGY, v.86, no.1, pp.33 - 39, 2009-07

8
Intratumoral depletion of regulatory T cells using CD25-targeted photodynamic therapy in a mouse melanoma model induces anti-tumoral immune responses

Oh, Dongsun; Kim, Heegon; Oh, Ji Eun; Jung, Hi Eun; Lee, Yun Soo; Park, Ji-Ho; Lee, Heung Kyu, ONCOTARGET, v.8, no.29, pp.47440 - 47453, 2017-07

9
Lenalidomide bypasses CD28 co-stimulation to reinstate PD-1 immunotherapy by activating Notch signaling

Geng, Chen-Lu; Chen, Jun-Yi; Song, Tian -Yu; Jung, Jae Hyung; Long, Min; Song, Min -Fang; Ji, Tong; et al, CELL CHEMICAL BIOLOGY, v.29, no.8, pp.1260 - +, 2022-08

10
Novel anti-4-1BBxPD-L1 bispecific antibody augments anti-tumor immunity through tumor-directed T-cell activation and checkpoint blockade

Jeong, Seongju; Park, Eunyoung; Kim, Hyung-Don; Sung, Eunsil; Kim, Hyunjoo; Jeon, Jaehyoung; Kim, Youngkwang; et al, JOURNAL FOR IMMUNOTHERAPY OF CANCER, v.9, no.7, 2021

11
Potential Role of the Gut Microbiome In Colorectal Cancer Progression

Kim, Jaeho; Lee, Heung Kyu, FRONTIERS IN IMMUNOLOGY, v.12, 2022-01

12
Recruiting Cytotoxic T Cells to Folate-Receptor-Positive Cancer Cells

Kularatne, Sumith A.; Deshmukh, Vishal; Gymnopoulos, Marco; Biroc, Sandra L.; Xia, Jinming; Srinagesh, Shailaja; Sun, Ying; et al, ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, v.52, no.46, pp.12101 - 12104, 2013-11

13
Reprogramming of IL-12 secretion in the PDCD1 locus improves the anti-tumor activity of NY-ESO-1 TCR-T cells

Kim, Segi; Park, Cho I.; Lee, Sunhwa; Choi, Hyeong Ryeol; Kim, Chan Hyuk, FRONTIERS IN IMMUNOLOGY, v.14, 2023-01

14
Systematic Combination of Oligonucleotides and Synthetic Polymers for Advanced Therapeutic Applications

Han, Moohyun; Beon, Jiyun; Lee, Ju Young; Oh, Seung Soo, MACROMOLECULAR RESEARCH, v.29, no.10, pp.665 - 680, 2021-10

15
γδ T cells as a potential therapeutic agent for glioblastoma

Kang, In; Kim, Yumin; Lee, Heung Kyu, FRONTIERS IN IMMUNOLOGY, v.14, 2023-10

rss_1.0 rss_2.0 atom_1.0